Here, we provide solid evidence in mouse models that systemic vaccination with HPV mRNA-LNPs could induce robust expansion of both overall and HPV-specific CD8+ T cells, directing them towards IFN-response and exhaustion differentiation trajectories, thereby improving their anti-tumor efficiency. The gene discussed is IFNA1; the disease is neoplasm.